074430 — Aminologics Co Share Price
Last trade - 00:00- KR₩119bn
- KR₩88bn
- KR₩21bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.14 | ||
| Price to Tang. Book | 2.31 | ||
| Price to Free Cashflow | 49.67 | ||
| Price to Sales | 5.49 | ||
| EV to EBITDA | 35.25 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.61% | ||
| Return on Equity | 4.75% | ||
| Operating Margin | 9.41% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 18,980.4 | 17,650.77 | 22,848.96 | 27,336.93 | 20,886.62 | 332,000 | n/a | 2.51% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +197.03 | -76.32 | +61.87 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aminologics Co.,Ltd. is a Korea-based company mainly engaged in the manufacture and distribution of image processing chips for digital video recorders (DVRs). The Company operates its business through in two divisions: information technology (IT) division and amino acid division. Its IT division engages in the manufacture of DVR system-on-chips (SoCs), analog and digital integrated chips, multiplexer and display chips, color quad chips, video codec, peripheral component interconnect (PCI) one chips and others. Its amino acid division produces unnatural amino acids, which are used for pharmaceutical development. On July 29, 2013, the Company sold its entire shares of U-CHANG PLANT CONSTRUCTION CO., LTD. On December 23, 2013, Sam-Oh Pharm Co Ltd became the largest shareholder of the Company by acquiring a 16.67% stake in the Company.
Directors
- Jang Seok Oh CCE (61)
- Seong Seok Oh CCE (58)
- Yeon Jin Kim DRC (50)
- Gwang Sik Park DRC (57)
- Seong Cheol Park DRC (56)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- September 3rd, 1997
- Public Since
- June 4th, 2004
- No. of Shareholders
- 17,541
- No. of Employees
- 27
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 87,826,844
- Address
- 3F, SEOUL, 06244
- Web
- https://www.aminologics.co.kr/kor/main/
- Phone
- +82 27614570
- Auditors
- Seowoo Accounting Corporation
Upcoming Events for 074430
Similar to 074430
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
Ahn-Gook Pharmaceutical Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Anterogen Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 13:16 UTC, shares in Aminologics Co are trading at KR₩1,359. This share price information is delayed by 15 minutes.
Shares in Aminologics Co last closed at KR₩1,359 and the price had moved by -15.17% over the past 365 days. In terms of relative price strength the Aminologics Co share price has underperformed the FTSE Developed Asia Pacific Index by -17.15% over the past year.
There is no consensus recommendation for this security.
Aminologics Co does not currently pay a dividend.
Aminologics Co does not currently pay a dividend.
Aminologics Co does not currently pay a dividend.
To buy shares in Aminologics Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩1,359, shares in Aminologics Co had a market capitalisation of KR₩119bn.
Here are the trading details for Aminologics Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 074430
Based on an overall assessment of its quality, value and momentum Aminologics Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aminologics Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -2.42%.
As of the last closing price of KR₩1,359, shares in Aminologics Co were trading -4.86% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Aminologics Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩1,359.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Aminologics Co's management team is headed by:
- Jang Seok Oh - CCE
- Seong Seok Oh - CCE
- Yeon Jin Kim - DRC
- Gwang Sik Park - DRC
- Seong Cheol Park - DRC